MedPage Today on MSN

'Misleading' Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...

Bayer Accelerates Pharma Growth on High-Value Portfolio

On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus ...